Inverse Relationship between Viral Load and Genotypic Resistance Mutations in Korean Patients with Primary HIV Type 1 Infections

2006 ◽  
Vol 22 (11) ◽  
pp. 1142-1147 ◽  
Author(s):  
Bum Sik Chin ◽  
Juyeon Choi ◽  
Jeong-Gu Nam ◽  
Mee Kyung Kee ◽  
Soon Deok Suh ◽  
...  
2010 ◽  
Vol 26 (2) ◽  
pp. 217-221 ◽  
Author(s):  
Bum Sik Chin ◽  
Jun Yong Choi ◽  
Yang Han ◽  
Jiqiu Kuang ◽  
Yanling Li ◽  
...  

2008 ◽  
Vol 24 (9) ◽  
pp. 1209-1213 ◽  
Author(s):  
William Ian Towler ◽  
Jessica D. Church ◽  
James R. Eshleman ◽  
Mary Glenn Fowler ◽  
Laura A. Guay ◽  
...  

2005 ◽  
Vol 21 (4) ◽  
pp. 319-324 ◽  
Author(s):  
Dana Jones ◽  
Neil Parkin ◽  
Sarah E. Hudelson ◽  
Laura A. Guay ◽  
Philippa Musoke ◽  
...  

2016 ◽  
Vol 06 (03) ◽  
pp. 111-115
Author(s):  
Anoumou Dagnra ◽  
Abla Konou ◽  
Mounerou Salou ◽  
Pascal Kodah ◽  
Damobé Kombate ◽  
...  

2011 ◽  
Vol 27 (7) ◽  
pp. 797-801 ◽  
Author(s):  
Jonathan Dean ◽  
Thu Hong Ta Thi ◽  
Linda Dunford ◽  
Michael J. Carr ◽  
Linh Thuy Nguyen ◽  
...  

1999 ◽  
Vol 123 (11) ◽  
pp. 1011-1014
Author(s):  
Frederick S. Nolte

Abstract Quantitative human immunodeficiency virus (HIV) type 1 RNA tests have been essential tools in increasing our understanding of HIV pathogenesis and antiretroviral therapy. The plasma HIV RNA level is among the most powerful predictive tests in modern medicine for disease progression and has rapidly become the standard of practice for guiding clinicians in initiating, monitoring, and changing antiretroviral therapy. In this article the scientific rationale and clinical indications for viral load testing in HIV infection are reviewed.


2011 ◽  
Vol 27 (1) ◽  
pp. 71-80 ◽  
Author(s):  
B. Chaplin ◽  
G. Eisen ◽  
J. Idoko ◽  
D. Onwujekwe ◽  
E. Idigbe ◽  
...  

1997 ◽  
Vol 13 (4) ◽  
pp. 327-335 ◽  
Author(s):  
S.M. BRUISTEN ◽  
P.H.J. FRISSEN ◽  
P. VAN SWIETEN ◽  
P.R. HARRIGAN ◽  
I. KINGHORN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document